CURA — Curaleaf Holdings Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapContrarian

Annual cashflow statement for Curaleaf Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2020 December 31st	C2021 December 31st	C2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-56.8	-215	-265	-239	-216
Depreciation
Deferred Taxes
Non-Cash Items	-59	89.2	95.2	100	79.6
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital	28.6	-55.8	66	32	104
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Net Change in Other Assets & Liabilities
Cash from Operating Activities	4.27	-58.3	46.4	75.3	163
Capital Expenditures	-126	-172	-135	-70.3	-98.2
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-70.8	7.98	-85.2	-8.38	4.32
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-197	-164	-220	-78.7	-93.8
Financing Cash Flow Items	-2.51	36.2	-13.8	-15.7	-11.8
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	224	449	41.8	-67	-54.2
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	31.2	226	-136	-71.4	15.4